Caumont, Charline <br/><br/>
Neuroendocrine phenotype as an acquired resistance mechanism in ALK-rearranged lung adenocarcinoma.  [electronic resource] 

 -  Lung cancer (Amsterdam, Netherlands)  Feb 2016 
 - 15-8 p.  digital 
<br/><br/> Publication Type: Case Reports; Journal Article 
<br/><br/><label>ISSN: </label>1872-8332 
<br/><br/><label>Standard No.: </label>10.1016/j.lungcan.2015.12.001  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adenocarcinoma--drug therapy<br/>Adenocarcinoma of Lung<br/>Anaplastic Lymphoma Kinase<br/>Clavicle--pathology<br/>Crizotinib<br/>Drug Resistance, Neoplasm<br/>Female<br/>Gene Rearrangement<br/>Humans<br/>Lung Neoplasms--drug therapy<br/>Middle Aged<br/>Neuroendocrine Tumors--pathology<br/>Protein Kinase Inhibitors--therapeutic use<br/>Pyrazoles--therapeutic use<br/>Pyridines--therapeutic use<br/>Receptor Protein-Tyrosine Kinases--genetics